Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 36.01% is 22% below its 5-year average of 46.28%, around the middle of its 5-year range (3.83%–69.24%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.29% below its 12-month average of 38.42%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 36.01%.
DEBT TO ASSETS RATIO
36.01%
DEBT TO ASSETS RATIO AVG TTM
38.42%
DEBT TO ASSETS RATIO AVG 3Y
53.62%
DEBT TO ASSETS RATIO AVG 5Y
46.28%
DEBT TO ASSETS RATIO AVG 10Y
34.49%
DEBT TO ASSETS RATIO AVG 15Y
31.91%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-6.29%
CURRENT VS 3Y AVG
-32.85%
CURRENT VS 5Y AVG
-22.19%
CURRENT VS 10Y AVG
+4.39%
CURRENT VS 15Y AVG
+12.85%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+39908.01%
vs the sector median at left
Nutex Health, Inc.
Market Cap
$1.52B
Debt to Assets Ratio
36.01%
TTM Avg
38.42%
3Y Avg
53.62%
5Y Avg
46.28%
Market Cap
$1.51B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.54B
Debt to Assets Ratio
0.84%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.49B
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.57B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutex Health, Inc. (NUTX) | $1.52B | 36.01% | 38.42% | 53.62% | 46.28% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 0.25% | N/A | N/A | N/A |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 0.84% | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.55B | 0.16% | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 0.53% | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | 0.01% | N/A | N/A | N/A |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.48B | 0.02% | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.47B | 0.00% | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | 0.11% | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.45B | 0.21% | N/A | N/A | N/A |
Debt/Assets
36.0%
Debt/Equity
0.88
Current Ratio
5.00
Interest Coverage
12.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 36.01% |
| 2026-03-31 | 36.46% |
| 2025-12-31 | 38.26% |
| 2025-09-30 | 40.33% |
| 2025-06-30 | 41.05% |
| 2025-03-31 | 44.80% |
| 2024-12-31 | 51.93% |
| 2024-09-30 | 69.16% |
| 2024-06-30 | 68.33% |
| 2024-03-31 | 67.38% |
| 2023-12-31 | 69.24% |
| 2023-09-30 | 68.33% |
| 2023-06-30 | 65.76% |
| 2023-03-31 | 65.54% |
| 2022-12-31 | 61.89% |
| 2022-09-30 | 60.19% |
| 2022-06-30 | 28.35% |
| 2022-03-31 | 5.49% |
| 2021-12-31 | 45.24% |
| 2021-09-30 | 3.83% |
| 2021-06-30 | 4.27% |
| 2021-03-31 | 3.30% |
| 2020-12-31 | 48.65% |
| 2020-09-30 | 12.86% |
| 2020-06-30 | 46.33% |
| 2020-03-31 | 49.97% |
| 2019-12-31 | 41.14% |
| 2019-09-30 | 28.29% |
| 2019-06-30 | 22.94% |
| 2019-03-31 | 11.77% |
| 2018-12-31 | 17.67% |
| 2018-09-30 | 3.04% |
| 2018-06-30 | 2.68% |
| 2018-03-31 | 2.24% |
| 2017-12-31 | 11.60% |
| 2017-09-30 | 1.04% |
| 2017-06-30 | 0.89% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.14% |
